EGFR and non-small cell lung carcinoma: The sensitivity of molecular techniques used for the detection of EGFR gene mutations is a critical factor in NSCLC diagnosis and subsequent treatment, since the results of these tests may affect qualification for TKI-EGFR-based therapy and the effectiveness of such therapies.